Offer - Urjas Oil for just ₹ 1 X
Ismo Retard Tablet ER (7) is a prescription drug, available for use as Tablet. Primarily, it is used for the treatment of Angina.
The optimal dosage of Ismo Retard Tablet ER (7) is largely dependent on the individual's body weight, medical history, gender and age. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. For detailed information on this, read through the dosage section.
Common side effects of Ismo Retard Tablet ER (7) include Headache, Dizziness, Flushing. Besides the aforementioned side effects, there are other adverse effects of Ismo Retard Tablet ER (7) as well, which are listed below. These side effects of Ismo Retard Tablet ER (7) are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Ismo Retard Tablet ER (7)'s effect during pregnancy is Mild and Mild while nursing. Further, the section on Ismo Retard Tablet ER (7) related warnings talks about Ismo Retard Tablet ER (7)'s effects on the liver, heart and kidney.
Ismo Retard Tablet ER (7) is contraindicated in people with pre-existing medical conditions like Low Blood Pressure (Hypotension), Anemia as it can result in adverse effects. The section on Ismo Retard Tablet ER (7) contraindications lists all such conditions.
Besides this, Ismo Retard Tablet ER (7) may also have severe interaction with some medicines. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Ismo Retard Tablet ER (7) is considered not safe while driving, and is not addictive.
Ismo Retard Tablet ER (7) is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Ismo Retard Tablet ER (7) safe for pregnant women?
Ismo has little to no side effects in pregnant women.
Is the use of Ismo Retard Tablet ER (7) safe during breastfeeding?
Breastfeeding women can take Ismo as it bears very minor side effects for them.
What is the effect of Ismo Retard Tablet ER (7) on the Kidneys?
Ismo is not harmful for kidneys.
What is the effect of Ismo Retard Tablet ER (7) on the Liver?
Ismo does not damage the liver.
What is the effect of Ismo Retard Tablet ER (7) on the Heart?
Ismo may have mild side effects on the heart. Most people will never see any effect on the heart.
Ismo Retard Tablet ER (7) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Ismo Retard Tablet ER (7) unless your doctor advises you to do so -
Is this Ismo Retard Tablet ER (7) habit forming or addictive?
No, there is no any evidence that Ismo Retard Tablet ER (7) is addictive.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Ismo Retard Tablet ER (7) can make you feel drowsy.
Is it safe?
Yes, but consume Ismo Retard Tablet ER (7) only on doctor's advice.
Is it able to treat mental disorders?
No, the use of Ismo Retard Tablet ER (7) in mental disorders is not effective.
Interaction between Food and Ismo Retard Tablet ER (7)
Information is not available on the interaction of any foods with Ismo Retard Tablet ER (7), due to a lack of research on this.
Interaction between Alcohol and Ismo Retard Tablet ER (7)
Due to lack of research, there is no information about the side effects of taking Ismo Retard Tablet ER (7) with alcohol.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; monoket® (isosorbide mononitrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 544
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 716-718